Ticker League

Moderna (MRNA) Profit Bridge

See what drove Moderna's net income from TTM through Q1 2025 to TTM through Q1 2026 — every line ranked by dollar impact, from revenue gains to taxes.

TTM

Revenue YoY

-29.12%

Operating Income YoY

+8.50%

Net Income YoY

+4.90%

Net Margin Δ

-3666 bps

Net income bridge for Moderna (MRNA) — TTM through Q1 2026 vs TTM through Q1 2025

Δ Net income: $163.00M+4.90%

Profit bridge breakdown for Moderna (MRNA) — TTM through Q1 2026 vs TTM through Q1 2025

  • Prior Net Income−$3.36B
  • Revenue−$914.00M
  • Cost of Revenue−$1.08B
  • Operating Expenses$2.31B
  • Other Income / Expense−$49.00M
  • Income Tax−$105.00M
  • Net Loss−$3.19B
Identity check: drivers reconcile to ΔNI within $0.00
Want the full P&L structure?Income Statement Waterfall

Frequently asked questions

Data & methodology

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation